Briol, Tertulo M.

HRN: 22-75-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2023
MUPIROCIN 2%, 15G (TUBE)
03/16/2023
03/23/2023
TOPICAL
15g
Bid
Malignant Otitis Media Vs RHS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: